BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19803428)

  • 1. [Damage-associated molecular patterns and chronic diseases].
    Yang HZ; Cai WF; Hu ZW
    Sheng Li Ke Xue Jin Zhan; 2009 Jul; 40(3):234-40. PubMed ID: 19803428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis.
    Foell D; Wittkowski H; Roth J
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):382-90. PubMed ID: 17599072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationships between damage-associated molecular patterns and organ injury].
    Hagiwara S; Noguchi T
    Masui; 2013 Mar; 62(3):290-5. PubMed ID: 23544330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damage-Associated Molecular Patterns in the Course of Lung Cancer--A Review.
    Łagiedo M; Sikora J; Kaczmarek M
    Scand J Immunol; 2015 Aug; 82(2):95-101. PubMed ID: 25966741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors in autoimmunity.
    Fischer M; Ehlers M
    Ann N Y Acad Sci; 2008 Nov; 1143():21-34. PubMed ID: 19076342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.
    Foell D; Wittkowski H; Vogl T; Roth J
    J Leukoc Biol; 2007 Jan; 81(1):28-37. PubMed ID: 16943388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer.
    Boteanu RM; Suica VI; Uyy E; Ivan L; Dima SO; Popescu I; Simionescu M; Antohe F
    J Proteomics; 2017 Feb; 153():21-29. PubMed ID: 27840210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors in inflammation, infection and cancer.
    Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
    Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.
    Ionita MG; Arslan F; de Kleijn DP; Pasterkamp G
    J Innate Immun; 2010; 2(4):307-15. PubMed ID: 20431283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAMPs, ageing, and cancer: The 'DAMP Hypothesis'.
    Huang J; Xie Y; Sun X; Zeh HJ; Kang R; Lotze MT; Tang D
    Ageing Res Rev; 2015 Nov; 24(Pt A):3-16. PubMed ID: 25446804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of endogenous triggers on trauma-associated inflammation.
    Zedler S; Faist E
    Curr Opin Crit Care; 2006 Dec; 12(6):595-601. PubMed ID: 17077693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock proteins and high mobility group box 1 protein lack cytokine function.
    Tsan MF
    J Leukoc Biol; 2011 Jun; 89(6):847-53. PubMed ID: 21199932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity.
    Lotze MT; Zeh HJ; Rubartelli A; Sparvero LJ; Amoscato AA; Washburn NR; Devera ME; Liang X; Tör M; Billiar T
    Immunol Rev; 2007 Dec; 220():60-81. PubMed ID: 17979840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
    Karikó K; Weissman D; Welsh FA
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis.
    Wakefield D; Gray P; Chang J; Di Girolamo N; McCluskey P
    Br J Ophthalmol; 2010 Mar; 94(3):271-4. PubMed ID: 19264730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Damage-Associated Molecular Patterns in Inflammatory Diseases.
    Roh JS; Sohn DH
    Immune Netw; 2018 Aug; 18(4):e27. PubMed ID: 30181915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases.
    Ren W; Zhao L; Sun Y; Wang X; Shi X
    Mol Med; 2023 Sep; 29(1):117. PubMed ID: 37667233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between damage associated molecular patterns, pathogen associated molecular patterns, alarmins and inflammatory response].
    Luan ZG; Ma XC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):566-9. PubMed ID: 19751572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.